18
Participants
Start Date
April 20, 2025
Primary Completion Date
April 30, 2029
Study Completion Date
December 31, 2030
Rapidly generated virus specific T (R-MVST) cells
"Group A dose escalation schedule:~* Cohort (-1A): 0.25x10\^6 R-MVST TNC/kg~* Cohort (1A): 0.5x10\^6 R-MVST TNC/kg~* Cohort (2A): 1x10\^6 R-MVST TNC/kg~Groups B \& C dose escalation schedule:~* Cohort (-1B) + (-1C): 1x10\^6 R-MVST TNC/kg~* Cohort (1B) + (1C): 2x10\^6 R-MVST TNC/kg~* Cohort (2B) + (2C): 4x10\^6 R-MVST TNC/kg"
RECRUITING
Columbia University Medical Center / New-York Presbyterian, New York
Columbia University
OTHER